{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:10:54Z","timestamp":1791389454153,"version":"4.3.3"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008368","name":"Gigtforeningen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008368","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003035","name":"Aase og Ejnar Danielsens Fond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003035","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003554","name":"Lundbeckfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Immunological Methods"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.jim.2020.112866","type":"journal-article","created":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T22:08:13Z","timestamp":1600121293000},"page":"112866","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Complement activation in human autoimmune diseases and mouse models; employing a sandwich immunoassay specific for C3dg"],"prefix":"10.1016","volume":"486","author":[{"given":"Anne","family":"Troldborg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lene","family":"Halkj\u00e6r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Gitte","family":"Loft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanne","family":"Lindegaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristian","family":"Stengaard-Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas Heilskov","family":"Graversen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaseelan","family":"Palarasah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"Thiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jim.2020.112866_bb0005","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.15252\/embj.201591881","article-title":"Complement activation, regulation, and molecular basis for complement-related diseases","volume":"34","author":"Bajic","year":"2015","journal-title":"EMBO J."},{"key":"10.1016\/j.jim.2020.112866_bb0010","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1177\/0961203310371154","article-title":"The complex nature of serum C3 and C4 as biomarkers of lupus renal flare","volume":"19","author":"Birmingham","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.jim.2020.112866_bb0015","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/art.1780350606","article-title":"Derivation of the SLEDAI. A disease activity index for lupus patients. The committee on prognosis studies in SLE","volume":"35","author":"Bombardier","year":"1992","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jim.2020.112866_bb0020","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0022-1759(81)90107-1","article-title":"Double-decker rocket immunoelectrophoresis for direct quantitation of complement C3 split products with C3d specificities in plasma","volume":"44","author":"Brandslund","year":"1981","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jim.2020.112866_bb0025","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/ard.48.2.153","article-title":"Hypercatabolism of C3 and C4 in active and inactive systemic lupus erythematosus","volume":"48","author":"Charlesworth","year":"1989","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jim.2020.112866_bb0030","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.ajhg.2011.05.011","article-title":"Disease-causing mutations in genes of the complement system","volume":"88","author":"Degn","year":"2011","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.jim.2020.112866_bb0035","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1056\/NEJMoa061648","article-title":"The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria","volume":"355","author":"Hillmen","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.jim.2020.112866_bb0040","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0022-1759(87)90431-5","article-title":"A solid-phase anti-C3 assay for detection of immune complexes in six distinguished forms","volume":"98","author":"Iida","year":"1987","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jim.2020.112866_bb0045","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nature05172","article-title":"Structure of C3b reveals conformational changes that underlie complement activity","volume":"444","author":"Janssen","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.jim.2020.112866_bb0050","doi-asserted-by":"crossref","first-page":"6269","DOI":"10.1074\/jbc.RA117.001179","article-title":"A potent complement factor C3\u2013specific nanobody inhibiting multiple functions in the alternative pathway of human and murine complement","volume":"293","author":"Jensen","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jim.2020.112866_bb0055","series-title":"Complement and Complement Fixation","first-page":"133","author":"Kabat","year":"1967"},{"key":"10.1016\/j.jim.2020.112866_bb0060","first-page":"420","article-title":"Association of blood concentrations of complement split product iC3b and serum C3 with systemic lupus erythematosus disease activity","volume":"71","author":"Kim","year":"2019","journal-title":"Arthritis Rheumatol. John Wiley and Sons Inc"},{"key":"10.1016\/j.jim.2020.112866_bb0065","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1084\/jem.156.1.205","article-title":"Breakdown of C3 after complement activation. Identification of a new fragment C3g, using monoclonal antibodies","volume":"156","author":"Lachmann","year":"1982","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jim.2020.112866_bb0070","doi-asserted-by":"crossref","DOI":"10.1186\/1756-0500-7-716","article-title":"A non-synonymous single-nucleotide polymorphism in the gene encoding toll-like receptor 3 (TLR3) is associated with sero-negative rheumatoid arthritis (RA) in a Danish population","volume":"7","author":"Laska","year":"2014","journal-title":"BMC Res. Notes"},{"key":"10.1016\/j.jim.2020.112866_bb0075","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/978-1-59745-324-0_7","article-title":"Biotinylation of antibodies","volume":"588","author":"Mao","year":"2010","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jim.2020.112866_bb0080","article-title":"Plasma C4d as marker for lupus nephritis in systemic lupus erythematosus","volume":"19","author":"Martin","year":"2017","journal-title":"Arthritis Res. Ther. BioMed Central Ltd"},{"key":"10.1016\/j.jim.2020.112866_bb0085","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1186\/s13075-017-1470-2","article-title":"Plasma C4d as marker for lupus nephritis in systemic lupus erythematosus","volume":"19","author":"Martin","year":"2017","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jim.2020.112866_bb0090","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3389\/fimmu.2015.00257","article-title":"Complement system part II role in immunity","volume":"6","author":"Merle","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jim.2020.112866_bb0095","first-page":"262","article-title":"Complement system part I - Molecular mechanisms of activation and regulation","volume":"6","author":"Merle","year":"2015","journal-title":"Front. Immunol. Front. Media SA"},{"key":"10.1016\/j.jim.2020.112866_bb0100","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0165-022X(94)90020-5","article-title":"A simple modification of Blum\u2019s silver stain method allows for 30 minute detection of proteins in polyacrylamide gels","volume":"28","author":"Nesterenko","year":"1994","journal-title":"J. Biochem. Biophys. Methods"},{"key":"10.1016\/j.jim.2020.112866_bb0105","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1042\/bj2680055","article-title":"Neoantigens in complement component C3 as detected by monoclonal antibodies. Mapping of the recognized epitopes by synthetic peptides","volume":"268","author":"Nilsson","year":"1990","journal-title":"Biochem. J."},{"key":"10.1016\/j.jim.2020.112866_bb0110","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1056\/NEJMc0808527","article-title":"Eculizumab for atypical hemolytic-uremic syndrome","volume":"360","author":"N\u00fcrnberger","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jim.2020.112866_bb0115","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.15252\/embj.201696173","article-title":"Functional and structural insight into properdin control of complement alternative pathway amplification","volume":"36","author":"Pedersen","year":"2017","journal-title":"EMBO J."},{"key":"10.1016\/j.jim.2020.112866_bb0120","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus","volume":"64","author":"Petri","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jim.2020.112866_bb0125","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/ki.2013.377","article-title":"C3 glomerulopathy consensus report","volume":"84","author":"Pickering","year":"2013","journal-title":"Kidney Int."},{"key":"10.1016\/j.jim.2020.112866_bb0130","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0009-8981(96)06378-4","article-title":"Time-resolved immunofluorometric assay of pregnancy-associated plasma protein A in maternal serum screening for Down\u2019s syndrome in first trimester of pregnancy","volume":"254","author":"Qin","year":"1996","journal-title":"Clin. Chim. Acta Elsevier"},{"key":"10.1016\/j.jim.2020.112866_bb0135","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2017-000236","article-title":"Cell-bound complement activation products in SLE","volume":"4","author":"Ramsey-Goldman","year":"2017","journal-title":"Lupus Sci. Med."},{"key":"10.1016\/j.jim.2020.112866_bb0140","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jim.2017.02.002","article-title":"A novel antihuman C3d monoclonal antibody with specificity to the C3d complement split product","volume":"444","author":"Rasmussen","year":"2017","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jim.2020.112866_bb0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/8051972","article-title":"Hypocomplementemia as a risk factor for organ damage accrual in patients with systemic lupus erythematosus","volume":"2018","author":"Raymond","year":"2018","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.jim.2020.112866_bb0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jcla.10100","article-title":"Reference distributions for complement proteins C3 and C4. A practical, simple and clinically relevant approach in a large cohort","volume":"18","author":"Ritchie","year":"2004","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/j.jim.2020.112866_bb0155","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/imr.12475","article-title":"Protection of host cells by complement regulators","volume":"274","author":"Schmidt","year":"2016","journal-title":"Immunol. Rev. NIH Public Access"},{"key":"10.1016\/j.jim.2020.112866_bb0160","first-page":"487","article-title":"Correlation of C3d fixing circulating immune complexes with disease activity and clinical parameters in patients with systemic lupus erythematosus","volume":"55","author":"Sekita","year":"1984","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jim.2020.112866_bb0165","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/acr.23317","article-title":"Developing and refining new candidate criteria for systemic lupus erythematosus classification an international collaboration","volume":"70","author":"Tedeschi","year":"2018","journal-title":"Arthritis Care Res. (Hoboken)"},{"key":"10.1016\/j.jim.2020.112866_bb0170","first-page":"63","article-title":"Acute complement activation during an anaphylactoid reaction to blood transfusion and the disappearance rate of C3c and C3d from the circulation","volume":"12","author":"Teisner","year":"1983","journal-title":"J. Clin. Lab. Immunol."},{"key":"10.1016\/j.jim.2020.112866_bb0175","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.00581","article-title":"The C3dg fragment of complement is superior to conventional C3 as a diagnostic biomarker in systemic lupus erythematosus","volume":"9","author":"Troldborg","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jim.2020.112866_bb0180","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.3899\/jrheum.171033","article-title":"The lectin pathway of complement activation in patients with systemic lupus erythematosus","volume":"45","author":"Troldborg","year":"2018","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jim.2020.112866_bb0185","first-page":"cei.13374","article-title":"Plasma levels of H- and L-ficolin are increased in axial spondyloarthritis improvement of disease identification","author":"Troldborg","year":"2019","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jim.2020.112866_bb0190","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2174\/1574887112666171128134552","article-title":"The emerging role of complement C3 as a biomarker of insulin resistance and cardiometabolic diseases preclinical and clinical evidence","volume":"13","author":"Ursini","year":"2018","journal-title":"Rev. Recent Clin. Trials"},{"key":"10.1016\/j.jim.2020.112866_bb0195","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.humpath.2018.07.008","article-title":"Role of complement system in patients with biopsy-proven immunoglobulin G4\u2013related kidney disease","volume":"81","author":"Wang","year":"2018","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.jim.2020.112866_bb0200","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1172\/JCI105555","article-title":"Evidence for in vivo breakdown of beta-10-globulin in hypocomplementemic glomerulonephritis","volume":"46","author":"West","year":"1967","journal-title":"J. Clin. Invest."}],"container-title":["Journal of Immunological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175920301605?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175920301605?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T16:35:17Z","timestamp":1758299717000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022175920301605"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":40,"alternative-id":["S0022175920301605"],"URL":"https:\/\/doi.org\/10.1016\/j.jim.2020.112866","relation":{},"ISSN":["0022-1759"],"issn-type":[{"value":"0022-1759","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Complement activation in human autoimmune diseases and mouse models; employing a sandwich immunoassay specific for C3dg","name":"articletitle","label":"Article Title"},{"value":"Journal of Immunological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jim.2020.112866","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"112866"}}